Treatment of refractory epilepsy with natalizumab in a patient with multiple sclerosis. Case report

BMC Neurology

Volumn 10, Issue , 2010, Pages

  Sotgiu, Stefano ^a   Murrighile, Maria R ^a   Constantin, Gabriela ^b  

^a UNIVERSITY OF SASSARI   (Italy)

^b UNIVERSITY OF VERONA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; DIAZEPAM; ETIRACETAM; GABAPENTIN; GLATIRAMER; LAMOTRIGINE; LORAZEPAM; METHYLPREDNISOLONE; NATALIZUMAB; OXCARBAZEPINE; PHENOBARBITAL; TOPIRAMATE; VALPROIC ACID; IMMUNOSUPPRESSIVE AGENT; MONOCLONAL ANTIBODY; NEUROPROTECTIVE AGENT; PEPTIDE;

ABSENCE OF SIDE EFFECTS; ADULT; ARTICLE; CASE REPORT; CEREBELLAR ATAXIA; CEREBROSPINAL FLUID ANALYSIS; DIFFERENTIAL DIAGNOSIS; DIPLOPIA; DISEASE ACTIVITY; DISEASE EXACERBATION; DRUG DOSE REDUCTION; DRUG EFFECT; DRUG TOLERABILITY; DYSMETRIA; EPILEPTIC STATE; GRAND MAL SEIZURE; HUMAN; MALE; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; NYSTAGMUS; RELAPSE; TONIC CLONIC SEIZURE; EPILEPSY; PATHOPHYSIOLOGY;

ANTIBODIES, MONOCLONAL; ANTICONVULSANTS; EPILEPSY; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; METHYLPREDNISOLONE; MULTIPLE SCLEROSIS; NEUROPROTECTIVE AGENTS; PEPTIDES; YOUNG ADULT;

EID: 77956875172     PISSN: None     EISSN: 14712377     Source Type: Journal    
DOI: 10.1186/1471-2377-10-84     Document Type: Article

References (35)

1. Noseworthy JH, Lucchinetti C, Rodriguez M, Weinshenker BG. Multiple sclerosis. N Engl J Med 2000, 343:938-952. 10.1056/NEJM200009283431307, 11006371.
2. McFarland HF, Martin R. Multiple sclerosis: a complicated picture of autoimmunity. Nat Immunol 2007, 8:913-919. 10.1038/ni1507, 17712344.
3. Stone LA, Smith ME, Albert PS, Bash CN, Maloni H, Frank JA, McFarland HF. Blood-brain barrier disruption on contrast-enhanced MRI in patients with mild relapsing-remitting multiple sclerosis: relationship to course, gender, and age. Neurology 1995, 45:1122-1126.
4. Polman CH, Reingold SC, Edan G, Filippi M, Hartung HP, Kappos L, Lublin FD, Metz LM, McFarland HF, O'Connor PW, Sandberg-Wollheim M, Thompson AJ, Weinshenker BG, Wolinsky JS. Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria". Ann Neurol 2005, 58:840-846. 10.1002/ana.20703, 16283615.
5. Koch M, Uyttenboogaart M, Polman S, De Keiser J. Seizures in multiple sclerosis. Epilepsia 2008, 49:948-953. 10.1111/j.1528-1167.2008.01565.x, 18336559.
6. Zaccara G. Neurological comorbidity and epilepsy: implications for treatment. Acta Neurol Scand 2009, 120:1-15. 10.1111/j.1600-0404.2008.01146.x, 19527225.
7. Vezzani A, Granata T. Brain inflammation in epilepsy: experimental and clinical evidence. Epilepsia 2005, 46:1724-1743. 10.1111/j.1528-1167.2005.00298.x, 16302852.
8. Ransohoff RM. Immunology: Barrier to electrical storms. Nature 2009, 457:155-156. 10.1038/457155a, 19129836.
9. Marchi N, Angelov L, Masaryk T, Fazio V, Granata T, Hernandez N, Hallene K, Diglaw T, Franic L, Najm I, Janigro D. Seizure-promoting effect of blood-brain barrier disruption. Epilepsia 2007, 48:732-742. 10.1111/j.1528-1167.2007.00988.x, 17319915.
10. Fabene PF, Navarro Mora G, Martinello M, Rossi B, Merigo F, Ottoboni L, Bach S, Angiari S, Benati D, Chakir A, Zanetti L, Schio F, Osculati A, Marzola P, Nicolato E, Homeister JW, Xia L, Lowe JB, McEver RP, Osculati F, Sbarbati A, Butcher EC, Constantin G. A role for leukocyte-endothelial adhesion mechanisms in epilepsy. Nat. Med 2008, 14:1377-1383. 10.1038/nm.1878, 19029985.
11. Kim JV, Kang SS, Dustin ML, McGavern DB. Myelomonocytic cell recruitment causes fatal CNS vascular injury during acute viral meningitis. Nature 2009, 457:191-195. 10.1038/nature07591, 2702264, 19011611.
12. Hildebrandt M, Amann K, Schröder R, Pieper T, Kolodziejczyk D, Holthausen H, Buchfelder M, Stefan H, Blümcke I. White matter angiopathy is common in pediatric patients with intractable focal epilepsies. Epilepsia 2008, 49:804-815. 10.1111/j.1528-1167.2007.01514.x, 18266747.
13. Steinman L. Blocking adhesion molecules as therapy for multiple sclerosis: natalizumab. Nature Rev Drug Discov 2005, 4:510-519.
14. Steinman L. A molecular trio in relapse and remission in multiple sclerosis. Nat Rev Immunol 2009, 9:440-447. 10.1038/nri2548, 19444308.
15. Kurtzke JF. Rating neurological impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983, 33:1444-1452.
16. Sander J. The epidemiology of epilepsy revisited. Curr Opin Neurol 2003, 16:165-170. 10.1097/00019052-200304000-00008, 12644744.
17. Forsgren L, Beghi E, Oun A, Sillanpaa M. The epidemiology of epilepsy in Europe- a systematic review. Eur J Neurol 2005, 12:245-253. 10.1111/j.1468-1331.2004.00992.x, 15804240.
18. Beleza P. Refractory epilepsy: a clinically oriented review. Eur Neurol 2009, 62:65-71. 10.1159/000222775, 19521080.
19. Kelley BJ, Rodriguez M. Seizures in patients with multiple sclerosis: epidemiology, pathophysiology and management. CNS Drugs 2009, 23:805-815. 10.2165/11310900-000000000-00000, 2748351, 19739692.
20. Vezzani A, Balosso S, Ravizza T. The role of cytokines in the pathophysiology of epilepsy. Brain Behav Immun 2008, 22:797-803. 10.1016/j.bbi.2008.03.009, 18495419.
21. Ravizza T, Gagliardi B, Noé F, Boer K, Aronica E, Vezzani A. Innate and adaptive immunity during epileptogenesis and spontaneous seizures: evidence from experimental models and human temporal lobe epilepsy. Neurobiol Dis 2008, 29:142-160. 10.1016/j.nbd.2007.08.012, 17931873.
22. Aronica E, Boer K, van Vliet EA, Redeker S, Baayen JC, Spliet WG, van Rijen PC, Troost D, da Silva FH, Wadman WJ, Gorter JA. Complement activation in experimental and human temporal lobe epilepsy. Neurobiol Dis 2007, 26:497-511. 10.1016/j.nbd.2007.01.015, 17412602.
23. Maroso M, Balosso S, Ravizza T, Liu J, Aronica E, Iyer AM, Rossetti C, Molteni M, Casalgrandi M, Manfredi AA, Bianchi ME, Vezzani A. Toll-like receptor 4 and high-mobility group box-1 are involved in ictogenesis and can be targeted to reduce seizures. Nat Med 2010, 16:413-419. 10.1038/nm.2127, 20348922.
24. Seiffert E, Dreier JP, Ivens S, Bechmann I, Tomkins O, Heinemann U, Friedman A. Lasting blood-brain barrier disruption induces epileptic focus in the rat somatosensory cortex. J Neurosci 2004, 24:7829-7836. 10.1523/JNEUROSCI.1751-04.2004, 15356194.
25. Ivens S, Kaufer D, Flores LP, Bechmann I, Zumsteg D, Tomkins O, Seiffert E, Heinemann U, Friedman A. TGF-beta receptor-mediated albumin uptake into astrocytes is involved in neocortical epileptogenesis. Brain 2007, 130:535-547. 10.1093/brain/awl317, 17121744.
26. van Vliet EA, da Costa Araújo S, Redeker S, van Schaik R, Aronica E, Gorter JA. Blood-brain barrier leakage may lead to progression of temporal lobe epilepsy. Brain 2007, 130:521-534. 10.1093/brain/awl318, 17124188.
27. Alon R, Kassner PD, Carr MW, Finger EB, Hemler ME, Springer TA. The integrin VLA-4 supports tethering and rolling in flow on VCAM-1. J Cell Biol 1995, 128:1243-1253. 10.1083/jcb.128.6.1243, 2120426, 7534768.
28. Ramos CL, Huo Y, Jung U, Ghosh S, Manka DR, Sarembock IJ, Ley K. Direct demonstration of P-selectin- and VCAM-1-dependent mononuclear cell rolling in early atherosclerotic lesions of apolipoprotein E-deficient mice. Circ Res 1999, 84:1237-1244.
29. Johnston B, Kubes P. The alpha4-integrin: an alternative pathway for neutrophil recruitment?. Immunol Today 1999, 20:545-550. 10.1016/S0167-5699(99)01544-3, 10562704.
30. Librizzi L, Regondi MC, Pastori C, Frigerio S, Frassoni C, de Curtis M. Expression of adhesion factors induced by epileptiform activity in the endothelium of the isolated guinea pig brain in vitro. Epilepsia 2007, 48:743-751. 10.1111/j.1528-1167.2007.01047.x, 17386052.
31. Boer K, Jansen F, Nellist M, Redeker S, van den Ouweland AM, Spliet WG, van Nieuwenhuizen O, Troost D, Crino PB, Aronica E. Inflammatory processes in cortical tubers and subependymal giant cell tumors of tuberous sclerosis complex. Epilepsy Res 2008, 78:7-21. 10.1016/j.eplepsyres.2007.10.002, 18023148.
32. Schrempf W, Ziemssen T. Glatiramer acetate: mechanisms of action in multiple sclerosis. Autoimmun Rev 2007, 6:469-75. 10.1016/j.autrev.2007.02.003, 17643935.
33. Prat A, Biernacki K, Antel JP. Th1 and Th2 lymphocyte migration across the human BBB is specifically regulated by interferon beta and copolymer-1. J Autoimmun 2005, 24:119-24. 10.1016/j.jaut.2005.01.004, 15829404.
34. Kleen JK, Holmes GL. Brain inflammation initiates seizures. Nat Med 2008, 14:1377-83. 10.1038/nm1208-1309, 2710311, 19029985.
35. Wenning W, Haghikia A, Laubenberger J, et al. Treatment of progressive multifocal leukoencephalopathy associated with natalizumab. N Engl J Med 2009, 361:1075-1080. 10.1056/NEJMoa0810257, 19741228.